[1]Patent:US2010/113512,2010,A1
[2]Patent:US2011/124559,2011,A1
[3]Patent:CN102516115,2016,B.Locationinpatent:Paragraph0427-0429
119162-52-6 
 
benzyl4-(3'-(5-((tert-butoxycarbonyl)amino)isoxazol-3-yl)-1,1'-biphenyl-4-carbonyl)piperazine-1-carboxylate 
[1]CurrentPatentAssignee:FORMATHERAPEUTICS,INC.-WO2014/164749,2014,A1
119162-52-6 
 
tert-butyl(3-(4'-(piperazine-1-carbonyl)-1,1'-biphenyl-3-yl)isoxazol-5-yl)carbamate 
[1]CurrentPatentAssignee:FORMATHERAPEUTICS,INC.-WO2014/164749,2014,A1
119162-52-6 
 
tert-butyl(3-(4'-(4-(1-hydroxycyclopropane-1-carbonyl)piperazine-1-carbonyl)-1,1'-biphenyl-3-yl)isoxazol-5-yl)carbamate 
[1]CurrentPatentAssignee:FORMATHERAPEUTICS,INC.-WO2014/164749,2014,A1
119162-52-6 
 
(4-(3'-(5-aminoisoxazol-3-yl)-1,1'-biphenyl-4-carbonyl)piperazin-1-yl)(1-hydroxycyclopropyl)methanone 
[1]CurrentPatentAssignee:FORMATHERAPEUTICS,INC.-WO2014/164749,2014,A1